Bibliografía del artículo
1. Jemal A, Murray T, Ward E y col. Cancer statistics, 2005. CA Cancer J Clin 55:10-30, 2005.
2. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (Eds). World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press, 2004.
3. Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med 353:2477-2490, 2005.
4. Kovacs G, Akhtar M, Beckwith BJ y col. The Heidelberg classification of renal cell tumours. J Pathol 183:131-133, 1997.
5. Parwani AV, Husain AN, Epstein JI, Beckwith JB, Argani P. Low-grade myxoid renal epithelial neoplasms with distal nephron differentiation. Hum Pathol 32:506-512, 2001.
6. Hes O, Mora M, Perez-Montiel DM y col. Spindle and cuboidal renal cell carcinoma, a tumour having frequent association with nephrolithiasis: report of 11 cases including a case with hybrid conventional renal cell carcinoma/spindle and cuboidal renal cell carcinoma components. Histopathology 41:549-555, 2002.
7. Lloreta J, Corominas JM, Munné A y col. Low-grade spindle cell carcinoma of the kidney. Ultrastruct Pathol 22(1):83-90, 1998.
8. Srigley JR. Mucinous tubular and Spindle cell carcinoma. En: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editores. World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon, IARC Press, p. 40, 2004.
9. Arias LF, Blanco J, Hernández S, Bocardo G, González L. Características inmunofenotípicas y clínicas del carcinoma renal mucinoso tubular y de células fusiformes. Actas Urol Esp 30:649-654, 2006.
10. Kuroda N, Toi M, Hiroi M, Shuin T, Enzan H. Review of mucinous tubular and spindle-cell carcinoma of the kidney with a focus on clinical and pathobiological aspects. Histol Histopathol 20:221-224, 2005.
11. Owens CL, Argani P, Ali SZ. Mucinous tubular and spindle cell carcinoma of the kidney: cytopathologic findings. Diagn Cytopathol 35:593-596, 2007.
12. Otani M, Shimizu T, Serizawa H, Nagashima Y. Mucinous tubular and spindle cell carcinoma of the kidney: Report of a case with imprint cytologic features. Acta Cytol 50:680-682, 2006.
13. Fine SW, Argani P, DeMarzo AM y col. Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney. Am J Surg Pathol 30:1554-1560, 2006.
14. Pillay N, Ramdial PK, Cooper K, Batuule D. Mucinous tubular and spindle cell carcinoma with aggressive histomorphology-a sarcomatoid variant. Hum Pathol 2008 (en prensa).
15. Shen SS, Ro JY, Tamboli P y col. Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features. Ann Diagn Pathol 11:13-21, 2007.
16. Paner GP, Srigley JR, Radhakrishnan A y col. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution. Am J Surg Pathol 30:13-19, 2006.
17. Cossu-Rocca P, Eble JN, Delahunt B y col. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod Pathol 19:488-493, 2006.
18. MacLennan G, Farrow GM, Bostwick DG. Low-grade collecting duct carcinoma of the kidney: Report of 13 cases of lowgrade mucinous tubulocystic renal carcinoma of possible collecting duct origin. Urology 50:679-684, 1997.
19. Srigley JR, Eble JN. Collecting duct carcinoma of kidney. Semin Diagn Pathol 15:54-67, 1998.
20. Farah R, Ben-Izhak O, Munichor M, Cohen H. Low-grade renal collecting duct carcinoma. A case report with histochemical, immunohistochemical, and ultrastructural study. Ann Diagn Pathol 9:46-48, 2005.
21. MacLennan GT, Bostwick DG. Tubulocystic carcinoma, mucinous tubular and spindle cell carcinoma, and other recently described rare renal tumors. Clin Lab Med 25:393-416, 2005.
22. Azoulay S, Vieillefond A, Paraf F y col. Tubulocystic carcinoma of the kidney: a new entity among renal tumors. Virchows Arch 451:905-909, 2007.
23. Amin MB, MacLennan GT, Paraf F y col. Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 29 cases of a distinctive rare subtype of renal cell carcinoma. Mod Pathol 17:137A, 2004.
24. Radhakrishnan A, MacLennan GT, Hennigar RA y col. Ultrastructural and immunohistochemical (IHC) appraisal of tubulocystic carcinoma (TCCa) of the kidney: histogenetic and diagnostic implications. Mod Pathol 18:160A, 2005.
25. Silva FG, Nadasdy T, Laszik Z. Immunohistochemical and lectin dissection of the human nephron in health and disease. Arch Pathol Lab Med 117:1233-1239, 1993.
26. Yang XJ, Zhou M, Hes O y col. Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization. Am J Surg Pathol 32:177-187, 2008.
27. Arias LF, Hernández S, Bocardo G y col. Estudios auxiliares en el diagnóstico diferencial de tumores epiteliales renales con células granulares. Actas Urol Esp 32:194-201, 2008.
28. Argani P, Ladanyi M. Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions. In: Eble JN, Sauter G, Epstein JI, et al, eds. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon, France: IARC Press; pp. 37-38, 2004.
29. Argani P, Olgac S, Tickoo SK y col. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol 31:1149-1160, 2007.
30. Hemesath TJ, Steingrimsson E, McGill G y col. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 8:2770-2780, 1994.
31. Beckmann H, Su LK, Kadesch T. TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif. Genes Dev 4:167-179, 1990.
32. Argani P, Hawkins A, Griffin CA y col. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol 158:2089-2096, 2001.
33. Argani P, Antonescu CR, Illei PB y col. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 159:179-192, 2001.
34. Argani P, Antonescu CR, Couturier J y col. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol 26:1553-1566, 2002.
35. Weterman MA, Wilbrink M, Geurts van Kessel A. Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas. Proc Natl Acad Sci USA 93:15294-15298, 1996.
36. Clark J, Lu YJ, Sidhar SK y col. Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 15:2233-2239, 1997.
37. Meyer PN, Clark JI, Flanigan RC, Picken MM. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Am J Clin Pathol 128:70-79, 2007.